Oravig

Inflammation, Tinea Pedis, Dermatophytosis + 20 more
Treatment
20 Active Studies for Oravig

What is Oravig

MiconazoleThe Generic name of this drug
Treatment SummaryMiconazole is an antifungal medication used to treat yeast infections of the mucous membranes, in both the mouth and vagina. It is available in a variety of prescription and non-prescription forms, such as creams, gels, and tablets. The drug works by inhibiting the activity of a certain enzyme in fungi, which helps stop the spread of the infection. Miconazole has been available since 1974 and is generally well tolerated with low risk of resistance.
SUNMARK MICONAZOLE NITRATE antifungalis the brand name
image of different drug pills on a surface
Oravig Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
SUNMARK MICONAZOLE NITRATE antifungal
Miconazole
1991
255

Effectiveness

How Oravig Affects PatientsMiconazole is a medicine used to treat fungal infections. It works by blocking a certain enzyme that helps the fungus grow. When applied directly to the skin, it is not absorbed into the body and usually does not cause any side effects. However, people who use miconazole for intravaginal use should not use tampons or rely on contraceptives to prevent pregnancy or infection.
How Oravig works in the bodyMiconazole works in several ways to fight fungal infections. It blocks an enzyme that helps create the cell membrane of fungi, making it harder for them to survive. It also makes it harder for fungi to produce energy and survive in the body. Miconazole also causes fungi to produce a molecule called farnesol, which inhibits their ability to form biofilms, which are resistant to antibiotics. Lastly, farnesol stops fungi from pumping out drugs, making them more susceptible to miconazole.

When to interrupt dosage

The suggested measure of Oravig is based on the diagnosed condition, including Gastrointestinal candidiasis, Nail candida and Infection, Mixed. The dosage can be found in the table below and is contingent upon the approach of delivery (e.g. Topical or Aerosol, spray - Topical).
Condition
Dosage
Administration
Tinea
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Arthrodermataceae
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Inflammation
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Tinea Pedis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Dermatophytosis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Candidiasis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
cutaneous candidiasis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Yeast Infection
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Dermatitis, Seborrheic
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Candidiasis, Vulvovaginal
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Oropharyngeal Candidiasis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Tinea Cruris
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Ringworm
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Dermatitis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Onychomycosis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Cellulitis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Coinfection
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Hyperhidrosis
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Intertrigo
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical
Skin candida
, 0.02 mg/mg, 0.0206 mg/mg, 0.1 mg, 20.0 mg/mL, 0.002 mg/mg, 0.026 mg/mg, 0.04 mg/mg, 0.00002 mg/mg, 0.142 mg/mg, 0.0002 mg/mg, 200.0 mg/mg, 0.03 mg/mg, 0.013 mg/mg, 0.07 mg/mg, 0.0256 mg/mg, 0.02 mL/mL, 50.0 mg, 2.0 %, 400.0 mg, 1200.0 mg, 4.0 %, 100.0 mg, 0.03 mg/mL, 0.0025 mg/mg, 0.112 mg/mg, 0.0282 mg/mg, 200.0 mg, 0.02 mg/mL, 20.0 mg/mg, 40.0 mg, 0.1 mg/mg, 100.0 mg/mg, 0.06 mg/mg, 2.0 mg/mg, 0.2 mg/mg, 0.17 mg/mg
, Powder, Powder - Topical, Topical, Kit, Cream, Cream - Topical, Spray, Spray - Topical, Vaginal, Cream - Vaginal, Suppository - Vaginal, Suppository, Tincture, Tincture - Topical, Kit - Vaginal, Ointment, Ointment - Topical, Liquid, Liquid - Topical, Aerosol, spray, Aerosol, spray - Topical, Aerosol, powder, Aerosol, powder - Topical, Tablet, Tablet - Buccal, Buccal, Insert, Insert - Vaginal, Aerosol, Aerosol - Topical, Oral; Topical, Capsule; Cream; Kit, Capsule; Cream; Kit - Oral; Topical, Cream; Insert - Topical; Vaginal, Cream; Suppository - Topical; Vaginal, Topical; Vaginal, Cream; Insert, Cream; Suppository, Kit - Topical; Vaginal, Lotion, Lotion - Topical, Paste, Kit - Topical, Paste - Topical

Warnings

Oravig has two forbiddances and should not be used while encountering any of the conditions mentioned in the following table.Oravig Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Miconazole may interact with Pulse Frequency
There are 20 known major drug interactions with Oravig.
Common Oravig Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Miconazole.
Abrocitinib
Major
The metabolism of Abrocitinib can be decreased when combined with Miconazole.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Miconazole.
Acetylsalicylic acid
Major
The metabolism of Acetylsalicylic acid can be decreased when combined with Miconazole.
Albendazole
Major
The metabolism of Albendazole can be decreased when combined with Miconazole.
Oravig Toxicity & Overdose RiskTaking too much miconazole can lead to serious side effects such as headaches, skin irritation, diarrhea, nausea, vomiting, abdominal pain, and bad taste in the mouth. It is recommended that those who overdose on miconazole receive appropriate medical care and supportive measures. The lethal dose of miconazole for rats is 500mg/kg.
image of a doctor in a lab doing drug, clinical research

Oravig Novel Uses: Which Conditions Have a Clinical Trial Featuring Oravig?

203 active trials are underway to assess the potential of Oravig to alleviate Dermatophytosis, reduce Inflammation and abate Excessive Sweating and Body Odor.
Condition
Clinical Trials
Trial Phases
Inflammation
58 Actively Recruiting
Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4
Yeast Infection
0 Actively Recruiting
Onychomycosis
0 Actively Recruiting
Acne Vulgaris
2 Actively Recruiting
Phase 1, Phase 2, Early Phase 1
Candidiasis
0 Actively Recruiting
Dermatitis, Seborrheic
0 Actively Recruiting
Dermatophytosis
0 Actively Recruiting
cutaneous candidiasis
0 Actively Recruiting
Cellulitis
0 Actively Recruiting
Tinea Versicolor
0 Actively Recruiting
Skin candida
0 Actively Recruiting
Tinea Pedis
0 Actively Recruiting
Arthrodermataceae
0 Actively Recruiting
Kerion Celsi
0 Actively Recruiting
Candidiasis, Vulvovaginal
0 Actively Recruiting
Tinea Cruris
0 Actively Recruiting
Tinea
0 Actively Recruiting
Intertrigo
0 Actively Recruiting
Oropharyngeal Candidiasis
0 Actively Recruiting
Ringworm
0 Actively Recruiting

Oravig Reviews: What are patients saying about Oravig?

4Patient Review
6/16/2011
Oravig for Candidiasis Fungal Infection of the Oropharynx
I've had to deal with a lot of fungal infections due to my inhalers, and I've tried nystatin and dyflucan multiple times. They just don't work for me. This pill is expensive, but it does the job. It takes some time getting used to, but I feel that it's worth the price if it works.
2.7Patient Review
11/16/2011
Oravig for Candidiasis Fungal Infection of the Oropharynx
I've only been using this pill for a few days, so it's hard to judge its effectiveness yet. It's not too comfortable having it in my upper lip, but I'm getting used to it. It's also pretty pricey if you don't have insurance.
1.3Patient Review
9/15/2011
Oravig for Candidiasis Fungal Infection of the Oropharynx
This treatment was really bad for me. I had terrible dry mouth and started seeing hair in front of my eyes. I was so tired and exhausted all the time. I quit immediately and threw the bottle away. There has to be some other drug that will kill thrush. Fluconozole hasn't touched it after 6 rounds. :(
1Patient Review
1/12/2011
Oravig for Candidiasis Fungal Infection of the Oropharynx
I really didn't enjoy the sensation of something in my mouth for such a long period of time. It was difficult to keep in place and seemed to get bigger as time went on. I would not use this product again or recommend it to anyone else.
1Patient Review
1/30/2013
Oravig for Candidiasis Fungal Infection of the Oropharynx
I'm on my second 14-day supply of this drug and it still hasn't cleared up my thrush. Not to mention, it's extremely expensive. I wouldn't recommend this to anyone.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about oravig

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is oravig available?

"Although there are no therapeutically equivalent versions of Oravig currently available in the United States, it's important to be aware that there are online pharmacies which may attempt to sell illegal generic versions of the medication. These medications may be counterfeit and could potentially be unsafe."

Answered by AI

How do you take oravig?

"To use the Oravig buccal tablet, place the rounded side of the tablet against your gum and close your mouth. Press your finger gently against the side of your cheek for 30 seconds to make sure the tablet stays in place. Do not chew or swallow the tablet. Leave it in place until the next morning."

Answered by AI

What is oravig used for?

"Oral thrush is a condition that can be treated using Oravig (miconazole), an antifungal tablet that is dissolved in the patient's cheek. Oravig works by killing the fungus that causes yeast infections, by damaging its protective outer layer."

Answered by AI

What class of medication is oravig?

"Oravig is a prescription medication used to treat symptoms of Oropharyngeal Candidiasis. Oravig may be used alone or in combination with other medications. Oravig belongs to a class of drugs called "Antifungals, Other.""

Answered by AI

Clinical Trials for Oravig

Image of UConn Health in Farmington, United States.

Cognitive Remediation for Memory and Thinking Difficulties

18+
All Sexes
Farmington, CT
The goal of this clinical trial is to determine if a neuroscience-based computerized cognitive remediation ("brain training") program can treat neurocognitive dysfunction (i.e., memory or thinking difficulties) that emerges in some older adults following a viral infection. The main questions it aims to answer are: * Does computerized cognitive remediation improve cognitive performance and day-to-day functioning in older adults with postviral neurocognitive dysfunction? * Will treatment effects be maintained over time, leading to better long term cognitive outcomes? * Does the treatment lead to reductions in blood-based markers of inflammation as a potential mechanism of cognitive symptom improvement? * Can the treatment be optimized and refined based on feedback from participants to improve user (patient) experience? Researchers will compare the computerized cognitive remediation program to an active computer-based control condition (alternative computer activities) to see if the computerized cognitive remediation program works to treat postviral neurocognitive dysfunction. Participation takes approximately 43-48 hours over 7 months, with most activities (40-46 hours) completed within the first 7-8 weeks, including: * Initial intake visit: Eligibility confirmation (\~2-3 hours) * Computer activities: About 5 hours per week for \~6 weeks (total \~30 hours) completed on a computer tablet provided by the study and loaned to participants for use during the treatment phase * Weekly remote check-in meetings: \~30 minutes each during treatment * Blood draws: Two sessions (before and after treatment), \~20-30 minutes each * Three research visits: Pre-treatment, post-treatment, and 6-month follow-up (\~2-3 hours each, including assessments of cognitive, emotional, and daily functioning)
Waitlist Available
Has No Placebo
UConn HealthCutter Lindbergh, Ph.D.
Have you considered Oravig clinical trials? We made a collection of clinical trials featuring Oravig, we think they might fit your search criteria.Go to Trials
Image of Abcentra Investigational Site in Los Angeles, United States.

Orticumab for Heart Attack

18+
All Sexes
Los Angeles, CA
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies
Phase 2
Recruiting
Abcentra Investigational Site (+6 Sites)Abcentra
Image of School of Public Health in Bloomington, United States.

High Salt Intake for High Blood Pressure

60 - 85
All Sexes
Bloomington, IN
Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs blood pressure control by affecting systemic blood vessels and the kidneys. These changes contribute to excess salt consumption being associated with increased risk for chronic kidney disease and cardiovascular disease, the leading cause of death in America. Salt is particularly deleterious in older adults who are more likely to exhibit salt-sensitive hypertension. However, salt consumption remains high in the United States. Thus, there is a critical need for strategies to counteract the effects of high dietary salt as consumption is likely not going to decrease. One promising option is ketones, metabolites that are produced in the liver during prolonged exercise and very low-calorie diets. While exercise and low-calorie diets are beneficial, not many people engage in these activities. Limited evidence indicates that ketone supplements improve cardiovascular health in humans. Additionally, published rodent data indicates that ketone supplements prevent high salt-induced increases in blood pressure, blood vessel dysfunction, and kidney injury. Our human pilot data also indicates that high dietary salt reduces intrinsic ketone production, but it is unclear whether ketone supplementation confers humans' protection against high salt similar to rodents. Therefore, the investigators seek to conduct a short-term high-dietary salt study to determine whether ketone supplementation prevents high dietary salt from eliciting increased blood pressure, blood vessel dysfunction, and kidney injury/impaired blood flow. The investigators will also measure inflammatory markers in blood samples and isolate immune cells that control inflammation. Lastly, the investigators will also measure blood ketone concentration and other circulating metabolites that may be altered by high salt, which could facilitate novel therapeutic targets to combat high salt.
Recruiting
Has No Placebo
School of Public Health
Image of Tesla MedBed at Tampa-FL in Tampa, United States.

Biophoton Therapy for Stem Cell Proliferation

18 - 70
All Sexes
Tampa, FL
Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can increase self-grown stem cells naturally. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in impacting stem cells. Approximately 46 volunteers who want to increase self-grown stem cells will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a serial of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants, will be blinded about who received which product during the first two weeks of study participation.
Recruiting
Online Trial
Tesla MedBed at Tampa-FL (+1 Sites)James Z Liu, MD, PhD
Have you considered Oravig clinical trials? We made a collection of clinical trials featuring Oravig, we think they might fit your search criteria.Go to Trials
Image of Goldring Center for High Performance Sport in Toronto, Canada.

Physical Activity for Delayed Onset Muscle Soreness

18 - 35
All Sexes
Toronto, Canada
After completing novel activity or exercise we may experience exercise-induced muscle damage (EIMD), resulting in a period of reduced muscle function and delayed onset muscle soreness (DOMS). DOMS is characterized by muscle pain and tenderness that typically resolves within a week. While the precise cause of DOMS is unknown, there is growing evidence implicating damage to the connective tissue that surrounds our muscle fibers and is related to a small amount of inflammation. This inflammation is a normal part of our body's ability to recovery from injuries and may be visualized through the use of ultrasound technology. A variety of recovery techniques have been proposed that may help with the recovery of DOMS such as massage and electrical muscle stimulation, but these are not always accessible. Therefore, we are interested in investigating whether the number of daily steps can affect how you experience DOMS.
Waitlist Available
Has No Placebo
Goldring Center for High Performance Sport
Image of UCSF in San Francisco, United States.

Moisturizers for Aging

65+
All Sexes
San Francisco, CA
This is a randomized, investigator-blinded, self-controlled pilot study of the physiologic response to topical moisturizers among older adults with dry skin. The overarching hypothesis is that skin barrier decline is an important source of chronic inflammation, and that skin barrier restoration with moisturizers can reduce serum biomarkers of inflammation. The primary objective is to determine the feasibility for a larger trial, and the secondary objectives are to determine the extent to which measures of serum inflammation, skin barrier function, and the skin microbiome change in response to moisturizers. Participants will be asked to apply one of two topical moisturizers that are widely available over the counter in the US (Vaseline® 100% pure petroleum jelly or CeraVe® moisturizing cream) once daily for 4 weeks to the front of the torso, buttocks, arms, and legs. Subjects will act as their own control (i.e. they will be asked to apply the study moisturizer they are randomized to for one intervention period (4 weeks) and not to apply topical moisturizers for the other 4- week intervention period). Participants will be randomized in a 1:1:1:1 ratio to one of 4 treatment groups: i. no intervention then CeraVe; ii. CeraVe then no intervention; iii. no intervention then Vaseline; iv. Vaseline then no intervention. At each visit (baseline, week 4, and week 8), participants will undergo skin barrier testing, skin microbiome sampling, and phlebotomy to measure serum inflammatory markers.
Phase 4
Recruiting
UCSFKatrina Abuabara, MD
Have you considered Oravig clinical trials? We made a collection of clinical trials featuring Oravig, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security